IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells

被引:95
作者
Brown, Deborah M. [1 ]
Kamperschroer, Cris [1 ]
Dilzer, Allison M. [1 ]
Roberts, Deborah M. [1 ]
Swain, Susan L. [1 ]
机构
[1] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
关键词
CD4; subsets; Cytotoxicity; Peptide dose; IL-2; Perforin; IN-VIVO; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SECRETING TH1; CUTTING EDGE; NAIVE CD4(+); PROTECTION; EFFECTOR; INFLUENZA; IMMUNITY;
D O I
10.1016/j.cellimm.2009.03.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD4 T cell effectors can promote survival against lethal influenza virus via perforin mediated cytolytic mechanisms; however, our understanding of how naive CD4 cells differentiate into class 11 restricted killers remains obscure. To address this, TCR Tg CD4 cells were activated in vitro and examined for their ability to lyse target cells. We found that cytokine polarized CD4 T cell effectors displayed cytolytic activity with the hierarchy Th0 > Th1 > Th2. Further, IL-4 inhibited the generation of cytotoxic CD4 cells. LPS stimulated B cells and bone marrow derived dendritic cells (BMDC) both induced potent cytolytic activity; however, IL-6, TGF-beta, IL-10, IL-12 or TNF-alpha were not required for inducing cytollytic activity in CD4 effectors. Antigen dose had a marked effect on cytotoxicity: low concentrations of peptide induced more potent cytolytic activity than relatively high concentrations. At low peptide concentration, exogenous IL-2 was necessary to drive granzyme B (GrB) expression and perforin mediated lysis. Thus, low antigen dose and early activation signals via IL-2 direct the CD4 T cell response toward effectors with perforin mediated cytolytic potential. These data have implications for the design of vaccines that may induce cytolytic CD4 cells in vivo and improve cell-mediated immunity to viral and bacterial infections. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 70 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]   High-avidity CD8+ T cells -: Optimal soldiers in the war against viruses and tumors [J].
Alexander-Miller, MA .
IMMUNOLOGIC RESEARCH, 2005, 31 (01) :13-24
[3]   Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4102-4107
[4]   The physiological role of cytotoxic CD4+T-cells: the holy grail? [J].
Appay, V .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (01) :10-13
[5]   Characterization of CD4+ CTLs ex vivo [J].
Appay, V ;
Zaunders, JJ ;
Papagno, L ;
Sutton, J ;
Jaramillo, A ;
Waters, A ;
Easterbrook, P ;
Grey, P ;
Smith, D ;
McMichael, AJ ;
Cooper, DA ;
Rowland-Jones, SL ;
Kelleher, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5954-5958
[6]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[7]  
BROMBERG JS, 1992, J IMMUNOL, V148, P3412
[8]   CD4 T cell-mediated protection from lethal influenza: Perforin and antibody-mediated mechanisms a one-two punch [J].
Brown, Deborah M. ;
Dilzer, Allison M. ;
Meents, Dana L. ;
Swain, Susan L. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :2888-2898
[9]   Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation [J].
Casazza, Joseph P. ;
Betts, Michael R. ;
Price, David A. ;
Precopio, Melissa L. ;
Ruff, Laura E. ;
Brenchley, Jason M. ;
Hill, Brenna J. ;
Roederer, Mario ;
Douek, Daniel C. ;
Koup, Richard A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (13) :2865-2877
[10]   Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement:: Correlation with CD8αβ versus CD8αα expression [J].
Cawthon, AG ;
Lu, HP ;
Alexander-Miller, MA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2577-2584